It was just a matter of time — though it took nearly 100 years — before Planned Parenthood would cancel its own founder, the suddenly “problematic” Margaret Sanger (1879–1966).
In an April 17 New York Times op-ed, Planned Parenthood President and CEO Alexis McGill Johnson admitted that “Up until now, Planned Parenthood has failed to own the impact of our founder’s actions. We have defended Sanger as a protector of bodily autonomy and self-determination while excusing her association with white supremacist groups and eugenics as an unfortunate ‘product of her time.’”
Sanger’s vision for limiting America’s black population through the championing of birth control and “healthcare services” is seamlessly outlined in her 1939 initiative “The Negro Project.” Sanger herself wrote about speaking at a Ku Klux Klan meeting in her autobiography and publicly supported the 1927 Supreme Court ruling Buck v. Bell, permitting the sterilization of “unfit” people without their consent. But Johnson is careful not to rush to judgment: “Whether our founder was a racist is not a simple yes or no question. Our reckoning is understanding her full legacy, and its impact. Our reckoning is the work that comes next.”
But while the organization conducts its “woke” investigation, and this trivia makes the national news, the nefarious evils of America’s largest abortion provider remain buried.
Planned Parenthood faces ongoing investigations by U.S. House and Senate committees into their involvement in human fetal tissue trafficking — a federal felony — and illegal profiting from transfers of organs harvested from aborted human fetuses, yet, it’s clear abortion alone does not satisfy the agency. So it’s not surprising they would have come up with other ways to turn a profit.
A harrowing report from Judicial Watch, published April 1, reveals that the U.S. Food and Drug Administration (FDA) has paid tens of thousands of taxpayer dollars to obtain human fetal tissue from the California-based “procurement” firm Advanced Bioscience Resources (ABR), undoubtedly supplied by abortion providers such as Planned Parenthood.
{modulepos inner_text_ad}
According to the report, the fetal tissue was used in a sort of Frankenstein project to create “humanized mice” to test “biologic drug products.” To this day, research continues unimpeded on these lifeless, preborn babies, as no one can provide consent for medical experimentation on an aborted fetus — certainly, the mother would not object, as she is not concerned about what happens to her aborted child.
Now the pro-abortion side would say that fetal experimentation is a complete myth concocted by “anti-choice” activists stirring the pot over a “trivialized harm.” Yet records of tissue purchases between ABR and government agencies prove the reality is far from being all in our minds.
Judicial Watch has acquired communications from January 2011 to April 2018 between ABR procurement manager Perrin Larton and FDA research veterinary medical official Dr. Kristina Howard, confirming the purchase of organs from aborted human fetuses.
In an e-mail dated September 27, 2012, Howard submitted an application to Larton for “tissue purchases” in the amount of $12,000. The contract reportedly requested tissue from an aborted fetus with a gestational age of 16 to 24 weeks and “One set of tissue (thymus/liver) approx. twice monthly.”
Instructions stated that the tissues were to be shipped “fresh; on wet ice.”
Judicial Watch President Tom Fitton, whose watchdog group has released two previous sets of records exposing unlawful transactions between ABR and the FDA, had these remarks on the findings:
These fetal organ trafficking documents shock the conscience and show potentially illegal use of tax dollars to purchase organs of the unborn killed through abortion.
According to 42 U.S. Code § 289g–2 — prohibitions regarding human fetal tissue, the purchase of human fetal tissue is “unlawful for any person who knowingly acquires, receive, or otherwise transfer any human fetal tissue for valuable consideration if the transfer affects interstate commerce.”
In March 2019, Judicial Watch moved forward with a Freedom of Information Act (FOIA) lawsuit against Health and Human Services (HHS), of which the FDA is a part (Judicial Watch v. U.S. Department Health and Human Services (No. 1:19-cv-00876). Additional records secured by the group demonstrate the National Institutes of Health (NIH) purchased aborted fetal parts for HIV research, paying “at least $18,100 between December 2016 and August 2018 to ABR for livers and thymuses from second trimester aborted fetuses.”
Judicial Watch reported that “ABR has been the subject of criminal referrals from House and Senate committees investigating whether Planned Parenthood or any other entity was illegally profiting from the handling of fetal tissue from aborted babies.”
However, in March 2018, government agency officials determined that purchasing human fetal tissue for research purposes was not protected by federal regulations.
An “overview” supplied by ABR describes the firm as a “non-profit corporate foundation … devoted to providing services in connection with the procurement of human organs and tissues for medical and scientific research.”
Yet such a statement is deceptive, as ABR is most certainly capitalizing on abortions performed every few seconds in this country. Meanwhile, Planned Parenthood rakes in triple the amount of money from one abortion, selling livers, brains, eyes, hearts — really whatever organs they can salvage. And now it’s up to the courts, and so far many judges have been complicit in continuing this evil, though they hold the power to stop it.
